Loading...
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro
Warfarin has had a thin margin of benefit over risk for the prevention of stroke and systemic embolism in patients with ESRD because of higher bleeding risks and complications of therapy. The successful use of warfarin has been dependent on the selection of patients with nonvalvular atrial fibrillat...
Na minha lista:
| Udgivet i: | Clin J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Nephrology
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5108189/ https://ncbi.nlm.nih.gov/pubmed/27797888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.02680316 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|